Compare CSPI & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSPI | CPIX |
|---|---|---|
| Founded | 1968 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.6M | 92.3M |
| IPO Year | 1994 | 2007 |
| Metric | CSPI | CPIX |
|---|---|---|
| Price | $8.22 | $7.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 66.9K | 64.0K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.15% | N/A |
| EPS Growth | ★ 75.00 | 58.70 |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $58,730,000.00 | $42,010,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $205.50 | ★ N/A |
| Revenue Growth | 6.36 | ★ 16.75 |
| 52 Week Low | $7.51 | $1.85 |
| 52 Week High | $15.00 | $7.36 |
| Indicator | CSPI | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 41.46 | 69.82 |
| Support Level | $7.76 | $5.42 |
| Resistance Level | $9.09 | N/A |
| Average True Range (ATR) | 0.49 | 0.62 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 35.14 | 94.63 |
CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.